Telogen Effluvium Induced by COVID-19
June 2023
in “
Piel
”
Research cited in this study
26 / 26 resultsresearch Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.
research Characteristics of Hair Loss After COVID-19: A Systematic Scoping Review
COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.
research Covid Induced Telogen Effluvium: An Insight
COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.
research Ultrastructural Evidence for Anagen Hair Follicle Infection with SARS-CoV-2 in Early-Onset COVID-19 Effluvium
COVID-19 may cause early hair loss by infecting hair follicles.
research Management of Hair Loss After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Insight Into the Pathophysiology With Implication for Better Management
Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.
research Alopecia in Patients with COVID-19: A Systematic Review and Meta-Analysis
Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.
research A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation
COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.
research COVID-19 Induced Telogen Effluvium
COVID-19 may cause temporary hair loss in some people.
research More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis
COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.
research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management
COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.
research Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium
Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.
research Telogen Effluvium in the New SARS-CoV-2 Era
COVID-19 and related stress may increase hair loss known as Telogen effluvium.
research Telogen Effluvium: A Review of the Science and Current Obstacles
The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.
research Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.
research SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study
COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.
research Acute Telogen Effluvium Associated with SARS-CoV-2 Infection
A woman's sudden hair loss was linked to her previous COVID-19 infection.
research Relative Changes in the Pattern of Diseases Presenting in Dermatology Outpatient Clinic in the Era of the COVID-19 Pandemic
During the COVID-19 pandemic, a clinic in Turkey saw fewer patients but more cases of certain skin conditions, possibly linked to the virus and stress.
research Telogen Effluvium: A Review of the Literature
The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.
research Telogen Effluvium: A Comprehensive Review
The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.
research Trichodynia: A Review of the Literature
Trichodynia is a painful scalp condition linked to hair loss and inflammation, often with anxiety, affecting more women and needing better treatment options.
research Telogen Effluvium: A Review
Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.
research Telogen Effluvium: A Review of Acute and Chronic Forms
Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.
research Enoxaparin-Induced Alopecia in Patients with Cerebral Venous Thrombosis
Some patients lost hair after being treated with the drug enoxaparin for a brain vein clot.
research Telogen Effluvium: Causes, Diagnosis, and Treatment
Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.
research Drug-Induced Hair Loss and Hair Growth
Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.
research Telogen Effluvium: A Comprehensive Review
Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.